SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 175 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $778,000 | -38.8% | 356,900 | +5.3% | 0.00% | -100.0% |
| Q2 2021 | $1,271,000 | +18.3% | 338,900 | +2.9% | 0.00% | 0.0% |
| Q1 2021 | $1,074,000 | -4.4% | 329,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,124,000 | -12.0% | 329,500 | +5.2% | 0.00% | 0.0% |
| Q3 2020 | $1,277,000 | +49.4% | 313,100 | +23.8% | 0.00% | 0.0% |
| Q2 2020 | $855,000 | +88.7% | 252,900 | +30.1% | 0.00% | – |
| Q1 2020 | $453,000 | -36.0% | 194,400 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $708,000 | -54.9% | 194,400 | +2.8% | 0.00% | -50.0% |
| Q3 2019 | $1,569,000 | -2.0% | 189,100 | +1.7% | 0.00% | 0.0% |
| Q2 2019 | $1,601,000 | -14.6% | 186,000 | +6.0% | 0.00% | 0.0% |
| Q1 2019 | $1,875,000 | +27.1% | 175,400 | +4.0% | 0.00% | 0.0% |
| Q4 2018 | $1,475,000 | -46.3% | 168,600 | +3.2% | 0.00% | -33.3% |
| Q3 2018 | $2,745,000 | -16.9% | 163,400 | +3.6% | 0.00% | -25.0% |
| Q2 2018 | $3,305,000 | +17.3% | 157,700 | -9.9% | 0.00% | +33.3% |
| Q1 2018 | $2,817,000 | +3.2% | 175,100 | +21.6% | 0.00% | 0.0% |
| Q4 2017 | $2,729,000 | +44.5% | 144,000 | +7.3% | 0.00% | +50.0% |
| Q3 2017 | $1,888,000 | +88.8% | 134,200 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $1,000,000 | +29.5% | 134,200 | +13.0% | 0.00% | 0.0% |
| Q1 2017 | $772,000 | +46.8% | 118,800 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $526,000 | -5.2% | 118,800 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $555,000 | -28.9% | 118,800 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $781,000 | +10.2% | 118,800 | +3.1% | 0.00% | 0.0% |
| Q1 2016 | $709,000 | +24.0% | 115,200 | +21.5% | 0.00% | 0.0% |
| Q4 2015 | $572,000 | +0.9% | 94,800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $567,000 | +0.5% | 94,800 | +14.9% | 0.00% | 0.0% |
| Q2 2015 | $564,000 | +17.7% | 82,500 | +4.6% | 0.00% | 0.0% |
| Q1 2015 | $479,000 | -12.4% | 78,900 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $547,000 | -14.8% | 78,900 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $642,000 | +0.2% | 78,900 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $641,000 | +3.6% | 78,900 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $619,000 | +11.5% | 78,900 | +25.8% | 0.00% | 0.0% |
| Q4 2013 | $555,000 | +9.5% | 62,700 | +3.8% | 0.00% | 0.0% |
| Q3 2013 | $507,000 | +6.5% | 60,400 | -5.3% | 0.00% | 0.0% |
| Q2 2013 | $476,000 | – | 63,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |